The store will not work correctly when cookies are disabled.
3-(Benzo[b]thiophen-5-carbamoyl)-N-hydroxy-4-methoxybenzamide
ID: ALA4865911
PubChem CID: 164620112
Max Phase: Preclinical
Molecular Formula: C17H14N2O4S
Molecular Weight: 342.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)NO)cc1C(=O)Nc1ccc2sccc2c1
Standard InChI: InChI=1S/C17H14N2O4S/c1-23-14-4-2-11(16(20)19-22)9-13(14)17(21)18-12-3-5-15-10(8-12)6-7-24-15/h2-9,22H,1H3,(H,18,21)(H,19,20)
Standard InChI Key: YANSTCQTALFESK-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.2562 -27.1210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9723 -26.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9695 -25.8778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2544 -25.4688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6819 -25.4628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3976 -25.8724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1101 -25.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8241 -25.8704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5362 -25.4561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5335 -24.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8128 -24.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1038 -24.6379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2516 -25.8661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2543 -26.6906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9643 -25.4515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6797 -25.8614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4006 -26.6969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3865 -24.2312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3803 -23.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5419 -26.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5384 -25.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7495 -25.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2653 -26.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7549 -26.9675 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 21 1 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
9 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
6 17 2 0
12 18 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.38 | Molecular Weight (Monoisotopic): 342.0674 | AlogP: 3.28 | #Rotatable Bonds: 4 |
Polar Surface Area: 87.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.20 | CX Basic pKa: ┄ | CX LogP: 2.63 | CX LogD: 2.62 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.50 | Np Likeness Score: -1.57 |
References
1. Ghazy E, Heimburg T, Lancelot J, Zeyen P, Schmidtkunz K, Truhn A, Darwish S, Simoben CV, Shaik TB, Erdmann F, Schmidt M, Robaa D, Romier C, Jung M, Pierce R, Sippl W.. (2021) Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis., 225 [PMID:34392190] [10.1016/j.ejmech.2021.113745] |